Benzinga
Benzinga
Benzinga
samedi, septembre 26

Aveanna Healthcare Holdings Inc

AVAHNASDAQ
Trade with Public
Trade with Public
$12.41
0.030.24%
À la clôture: Sep 25, 5:00 PM EST
$12.41
N/A
Après les heures: 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Aveanna Healthcare Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aveanna Healthcare Hldgs (AVAH).

Price Target Range — 9 Quarters

Analyst Consensus — 11 Analysts

1S.Buy
7Buy
3Hold
Consensus RatingNeutral# Analysts11Avg. Consensus PT$13Upside to Avg. PT+3.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 14, 2026JP MorganBenjamin RossiPT RaiseNeutral$8→$15
Aug 28, 2026BarclaysAndrew MokPT RaiseOverweight$10→$15
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $11 to $15.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $16.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $13.
Benzinga Newsdesk

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and raises the price target from $13 to $15.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved